Literature DB >> 24314001

A modified Delphi survey on the signs and symptoms of low back pain: indicators for an interventional management approach.

José Cid1, José L De La Calle, Esther López, Cristina Del Pozo, Alfredo Perucho, María Soledad Acedo, Dolores Bedmar, Javier Benito, Javier De Andrés, Susana Díaz, Juan Antonio García, Leticia Gómez-Caro, Adolfo Gracia, José María Hernández, Joaquín Insausti, María Madariaga, Pedro Moñino, Manuel Ruiz, Estrella Uriarte, Alfonso Vidal.   

Abstract

BACKGROUND: Low back pain (LBP) symptoms and signs are nonspecific. If required, diagnostic blocks may find the source of pain, but indicators of suspect diagnosis must be defined to identify anatomical targets.
OBJECTIVE: To reach a consensus from an expert panel on the indicators for the most common causes of LBP.
MATERIAL AND METHODS: A 3-round (2 telematic and 1 face-to-face) modified Delphi survey with a questionnaire on 78 evidence-based indicators of 7 LBP etiologies was completed by 23 experts.
RESULTS: 98.7% of the questionnaire was consensuated. The most accepted indicators were for zygapophysial joint pain, painful ipsilateral paravertebral palpation, worsening with trunk extension, paravertebral musculature spasm on the affected articulation, and referred pain above the knee, without radicular pattern. For sacroiliac joint pain, unilateral pain when seating, with at least 3 described provoking tests: Approximation; gapping; Patrick's; Gaenslen's; thigh thrust; Fortin finger; and Gillet's tests. For discogenic pain, midline pain that may be provoked by pressure on the spinal processes at the affected level; for quadratus lumborum muscle, painful palpation on both the L1 level paravertebral region, referred to iliac crest, and the iliac crest, referred to greater trochanter. For iliopsoas muscle, pain elicited by thigh flexion, referred to buttock, inguinal region, and anterior thigh. For pyramidal muscle, pain while sitting on the affected side and positive Freiberg's test. For radicular pain, paresthesias and positive Lassègue's test at 60°.
CONCLUSION: Seventy-seven diagnostic suspect indicators of LBP conditions were consensuated. These may facilitate conservative or interventional pain management decision-making.
© 2013 World Institute of Pain.

Entities:  

Keywords:  Delphi; back pain symptoms; chronic spinal pain; consensus statement; diagnostic blocks; interventional techniques; low back pain; lumbalgia; panel experts; signs

Mesh:

Year:  2013        PMID: 24314001     DOI: 10.1111/papr.12135

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  4 in total

1.  The effect of case-based discussion of topics with experts on learners' opinions: implications for spinal education and training.

Authors:  Pedro Berjano; Jorge Hugo Villafañe; Gerard Vanacker; Riccardo Cecchinato; Maryem Ismael; Robert Gunzburg; Daniele Marruzzo; Claudio Lamartina
Journal:  Eur Spine J       Date:  2016-11-14       Impact factor: 3.134

2.  The effect of case-based discussion of topics with experts on learners' opinions: implications for spinal education and training.

Authors:  Pedro Berjano; Jorge Hugo Villafañe; Gerard Vanacker; Riccardo Cecchinato; Maryem Ismael; Robert Gunzburg; Daniele Marruzzo; Claudio Lamartina
Journal:  Eur Spine J       Date:  2017-12-18       Impact factor: 3.134

Review 3.  Diagnostic criteria for musculoskeletal disorders for use in occupational healthcare or research: a scoping review of consensus- and synthesised-based case definitions.

Authors:  Henk F van der Molen; Steven Visser; Jose Hernán Alfonso; Stefania Curti; Stefano Mattioli; David Rempel; Yves Roquelaure; P Paul F M Kuijer; Sietske J Tamminga
Journal:  BMC Musculoskelet Disord       Date:  2021-02-11       Impact factor: 2.362

4.  The Impact of Chronic Discogenic Low Back Pain: Costs and Patients' Burden.

Authors:  José W Geurts; Paul C Willems; Jan-Willem Kallewaard; Maarten van Kleef; Carmen Dirksen
Journal:  Pain Res Manag       Date:  2018-10-01       Impact factor: 3.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.